RNU6-1015P

Across TCGA pan-cancer cohorts, RNU6-1015P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-1015P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNU6-1015P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1015P expression acts as an unfavorable survival marker.

SKCM, UCEC, and STAD are the cancer types where RNU6-1015P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.016	0.758	<.001	72	view →
UCEC	DFS	Tertile	All	0.627	0.900	<.001	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
KIRP	OS	Tertile	All	0.756	0.948	.028	9	view →
BRCA	OS	Tertile	All	0.780	0.963	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-1015P–SKCM (DFS)

Open the SKCM breakdown →